<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Master II en mécanique &amp; Génie mécanique</title>
<link href="http://dspace.univ-chlef.dz/handle/123456789/1055" rel="alternate"/>
<subtitle>Université Hassiba Benbouali de Chlef / Faculté de Technologie</subtitle>
<id>http://dspace.univ-chlef.dz/handle/123456789/1055</id>
<updated>2026-04-05T22:05:05Z</updated>
<dc:date>2026-04-05T22:05:05Z</dc:date>
<entry>
<title>Therapeutic Potential and Chemical Composition of Basil Essential Oil</title>
<link href="http://dspace.univ-chlef.dz/handle/123456789/2276" rel="alternate"/>
<author>
<name>SETRA, Ahmed Alaa Eddine</name>
</author>
<id>http://dspace.univ-chlef.dz/handle/123456789/2276</id>
<updated>2026-01-28T09:17:22Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Therapeutic Potential and Chemical Composition of Basil Essential Oil
SETRA, Ahmed Alaa Eddine
Basil essential oil, derived from the leaves of the Ocimum basilicum plant, has been widely&#13;
recognized for its extensive therapeutic properties. This review highlights its primary bioactive&#13;
compounds, such as linalool, eugenol, and methyl chavicol, which contribute to its&#13;
pharmacological activities. The oil exhibits potent anti-inflammatory, antimicrobial, antioxidant,&#13;
and analgesic properties, making it a valuable remedy in traditional and modern medicine. Studies&#13;
have shown its efficacy in reducing symptoms of stress and anxiety due to its calming effects on&#13;
the central nervous system. Additionally, basil essential oil demonstrates significant antibacterial&#13;
and antifungal activities, offering potential in the treatment of infections and skin conditions. Its&#13;
antioxidant properties help in combating oxidative stress, thus protecting cells from damage.&#13;
Furthermore, the oil has been found to alleviate pain and inflammation, making it beneficial in&#13;
managing conditions such as arthritis and muscle spasms. This comprehensive review underscores&#13;
the therapeutic potential of basil essential oil. Further research is warranted to explore its full&#13;
therapeutic potential and possible applications in integrative medicine.
THESIS&#13;
Presented for graduation from&#13;
MASTER&#13;
Speciality: Pharmaceutical Process Engineering
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Simulation of Continuous-Flow Pharmaceutical Production of Ibuprofen using ASPEN PLUS</title>
<link href="http://dspace.univ-chlef.dz/handle/123456789/2275" rel="alternate"/>
<author>
<name>SEDDIK, Lamia</name>
</author>
<id>http://dspace.univ-chlef.dz/handle/123456789/2275</id>
<updated>2026-01-28T09:15:48Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Simulation of Continuous-Flow Pharmaceutical Production of Ibuprofen using ASPEN PLUS
SEDDIK, Lamia
Ibuprofen, a widely used therapeutic molecule, has been identified as an ideal&#13;
candidate for continuous pharmaceutical manufacturing (CPM) due to its high global demand&#13;
and extreme societal importance. The development of a continuous production system for&#13;
ibuprofen aims to improve efficiency and reduce environmental impact. Based on the data&#13;
obtained through laboratory experiments and parameters calculated in this work, an industrialscale production with a capacity of 200 tons/year of ibuprofen salt was simulated using Aspen&#13;
Plus. This involves designing a steady-state process model and simulation for the continuous&#13;
synthesis and purification of ibuprofen, utilizing plug flow reactors and a final separation step&#13;
to achieve high API recovery
Dissertation Submitted in Partial Fulfillment of the&#13;
Requirements for the Degree of Master in Process Engineering&#13;
Speciality: Pharmaceutical Engineering
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Preparation and characterization of polymer film for the release of drugs</title>
<link href="http://dspace.univ-chlef.dz/handle/123456789/2274" rel="alternate"/>
<author>
<name>Aichouche, Hadjer</name>
</author>
<id>http://dspace.univ-chlef.dz/handle/123456789/2274</id>
<updated>2026-01-28T09:13:53Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Preparation and characterization of polymer film for the release of drugs
Aichouche, Hadjer
This work present a preparation and characterization of polymer films based on&#13;
methylene blue, alginate, agar, starch, glycerol and citric acid for the local treatment of&#13;
wounds.&#13;
In the first part we addresse traditional and current wound and treatment issues,&#13;
highlighting challenges in chronic wound treatment and advanced film systems for wound&#13;
treatment.&#13;
In the second part we intrdoduce polymer-based pharmaceutical films with methylene&#13;
blue as effective alternatives for administering wound treatment.&#13;
In the result we have films formation confirmed by IR spectroscopy(C=O, 1602cm-1&#13;
),&#13;
the crosslinking percentage (27⸓ for film 1, 80⸓for film2). For mthylene blue release, results&#13;
indicate the controlled release with (8.9 10-3 mg/ml) at (240 min) and (8.6 10-3 mg/ml) at (150&#13;
min) for film1 and film2 respectively.
Memory&#13;
Presented for master graduation&#13;
Field: Engineering&#13;
Option: Pharmaceutical Process Engineering
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Pharmacoinformatics-based identification process of phytochemicals against PARP-1 , HDACs and MDR as potential bioactive inhibitor compounds</title>
<link href="http://dspace.univ-chlef.dz/handle/123456789/2273" rel="alternate"/>
<author>
<name>MOSTEFAOUI, Hana</name>
</author>
<author>
<name>SAIAH DJEBBOUR, Ikram</name>
</author>
<id>http://dspace.univ-chlef.dz/handle/123456789/2273</id>
<updated>2026-01-28T09:11:35Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Pharmacoinformatics-based identification process of phytochemicals against PARP-1 , HDACs and MDR as potential bioactive inhibitor compounds
MOSTEFAOUI, Hana; SAIAH DJEBBOUR, Ikram
Heart failure and Colon cancer diseases are among the most common diseases in the world while&#13;
time. Treating these two diseases by targeting three specific proteins using molecules from different&#13;
plants will be a promising potential process. The object of this study is to inhibit the PARP-1; HDACs&#13;
and MDR receptors which are responsible for one of these two diseases respectively. After screening&#13;
of more than 21 plants original from chlef State, Algeria. We selected the citrus peels ; Thymus&#13;
vulgaris ; and Curcuma longa . The best ethanolic extracts yield is Citrus lemon peels (24.10%) and&#13;
Thymus Vulgaris have the best inhibitory activity against Staphylococcus aureus ATCC6538 (Gram&#13;
positive) with D=25mm. All the plants have antioxidant activity: IC50(Citrus)=0.198mg/ml , IC50(&#13;
Curcuma )=0.206mg/ml, IC50( Thymus)=0.187mg/ml .GC-MS analysis indicated several components&#13;
in extracts. The study conducted a pharmacoinformatics analysis “in silico” of 12compounds from 25&#13;
bioactive compounds. In silico studies reveal that the inhibitor ligand apigenine with PARP-1, forming&#13;
8 amino acid bonds with ∆G = -8.8 kcal/mol and thymonine interacts with HDAC1 forming 7 amino&#13;
acid bonds with ∆G = -7.6 kcal/mol . We finished our work with a new formulation which is emulgel.
Thesis&#13;
Presented for graduation from&#13;
MASTER2&#13;
Field: Process Engineering&#13;
Option: Pharmaceutical Process Engineering
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
</feed>
